Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Spear Pharmaceuticals

Spear Pharmaceuticals
1993 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and distributor of dermatological drugs. The company specializes in the research, development, manufacture and distribution of dermatological drugs also offering bioequivalent products that help restore skin health.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Parent Company
Primary Office
  • 13100 Ponderosa Way
  • Fort Myers, FL 33907
  • United States

+1 (239) 000-0000

Spear Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Spear Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Spear Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foamix Pharmaceuticals Formerly PE-Backed Rehovot, Israel 00 0000 000000000 0000
00000000 Corporate Backed or Acquired Dublin, Ireland 00000 000000&0
000000000 Corporate Backed or Acquired Menlo Park, CA 00 000.00 00000000 000.00
0000000 0000000000 Venture Capital-Backed Langhorne, PA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Spear Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
K. Spear President & Dermatologist
Stephen Basile Senior Vice President
Michael Langer Vice President
Rich Martin Vice President
Steve McGuire Vice President